Riboscience, Llc.
Clinical trials sponsored by Riboscience, Llc., explained in plain language.
-
New drug RBS2418 aims to rev up immune system against tough colorectal cancer
Disease control Recruiting nowThis Phase 2a trial tests an experimental drug called RBS2418 in 150 adults with advanced, metastatic colorectal cancer that has worsened despite standard treatments. The drug is designed to help the immune system recognize and attack cancer cells. Participants will receive eithe…
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New immunotherapy cocktail takes on tough liver tumors
Disease control Recruiting nowThis Phase 2 trial tests whether adding an experimental drug called RBS2418 to a standard immunotherapy regimen (tremelimumab plus durvalumab) can better control advanced liver cancer that cannot be removed by surgery. About 220 adults will receive either the combination or the s…
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental pill aims to rev up immune system against Hard-to-Treat tumors
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called RBS2418, taken as a pill, to see if it can help the immune system fight advanced cancers that have spread or come back. The study involves 164 adults with various solid tumors who have already tried standard treatments…
Phase: PHASE1 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC